Meineri Giorgia, Martello Elisa, Radice Elisabetta, Bruni Natascia, Saettone Vittorio, Atuahene David, Armandi Angelo, Testa Giulia, Ribaldone Davide Giuseppe
Department of Veterinary Sciences, School of Agriculture and Veterinary Medicine, University of Turin, 10095 Grugliasco, TO, Italy.
Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham NG5 1PB, UK.
Animals (Basel). 2022 Mar 23;12(7):812. doi: 10.3390/ani12070812.
Chronic intestinal disorders (CID) are characterized by persistent, or recurrent gastrointestinal (GI) signs present for at least three weeks. In human medicine, inflammatory bowel disease (IBD) is a group of chronic GI diseases and includes Crohn's disease (CD) and ulcerative colitis (UC). On the other hand, the general term chronic enteropathies (CE) is preferred in veterinary medicine. Different therapeutic approaches to these diseases are used in both humans and pets. This review is focused on the use of traditional therapies and nutraceuticals with specific antioxidant properties, for the treatment of CID in humans and animal patients. There is strong evidence of the antioxidant properties of the nutraceuticals included in this review, but few studies report their use for treating CID in humans and none in animals. Despite this fact, the majority of the nutraceuticals described in the present article could be considered as promising alternatives for the regular treatment of CID in human and veterinary medicine.
慢性肠道疾病（CID）的特征是持续或反复出现胃肠道（GI）症状，且症状持续至少三周。在人类医学中，炎症性肠病（IBD）是一组慢性胃肠道疾病，包括克罗恩病（CD）和溃疡性结肠炎（UC）。另一方面，在兽医学中更倾向使用“慢性肠病”（CE）这一通用术语。人类和宠物针对这些疾病采用了不同的治疗方法。本综述聚焦于使用具有特定抗氧化特性的传统疗法和营养保健品，用于治疗人类和动物患者的CID。本综述中所包含的营养保健品具有抗氧化特性，这有充分的证据，但很少有研究报告其用于治疗人类CID，且没有研究报告其用于治疗动物CID。尽管如此，本文所述的大多数营养保健品可被视为人类和兽医学中常规治疗CID的有前景的替代方案。
